Seres Therapeutics Inc. (MCRB)
NASDAQ: MCRB
· Real-Time Price · USD
16.70
-0.16 (-0.95%)
At close: Aug 15, 2025, 3:59 PM
16.08
-3.74%
After-hours: Aug 15, 2025, 07:58 PM EDT
Seres Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 45.38M | 58.85M | 30.79M | 66.82M | 71.23M | 111.18M | 127.97M | 169.91M | 229.52M | 94.84M | 163.03M | 205.4M | 126.82M | 153.19M | 180M | 227.46M | 74M | 66.58M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 11.7M | 18.31M | 27.61M | 68.97M | 94.81M | 110.7M | 119.93M | 140.56M | 176.22M |
Long-Term Investments | 8.67M | n/a | n/a | n/a | n/a | 9.83M | 9.59M | 9.59M | 9.59M | 9.59M | 9.59M | n/a | 9.59M | 9.59M | 495K | 5.79M | 14.88M | 29.75M |
Other Long-Term Assets | 31K | 8.7M | 8.7M | 10.34M | 51.39M | 41.47M | 41.35M | 12.05M | 11.25M | 11.31M | 10.46M | 21.12M | 9.51M | 1.74M | 14.59M | 2.75M | 2.75M | 2M |
Receivables | 882K | 4.38M | 4.75M | n/a | 18.6M | 7.42M | 8.67M | 16.86M | 7.56M | n/a | n/a | n/a | n/a | n/a | n/a | 1.25M | 1.25M | 2.6M |
Inventory | n/a | n/a | n/a | n/a | 53M | 41.97M | 29.65M | 18.52M | 5.34M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 2.42M | 2.85M | 3.13M | 6.1M | 6.43M | 4.61M | 9.12M | 9.1M | 8.82M | 9.54M | 13.42M | 14.51M | 13.79M | 15.25M | 12.92M | 10.17M | 8.75M | 6.57M |
Total Current Assets | 48.69M | 66.08M | 38.67M | 72.93M | 149.26M | 165.18M | 175.41M | 214.39M | 251.24M | 116.08M | 194.76M | 247.51M | 209.58M | 263.25M | 303.63M | 358.81M | 224.56M | 251.98M |
Property-Plant & Equipment | 86.42M | 89.41M | 92.44M | 95.48M | 121.08M | 124.78M | 132.25M | 131.67M | 134.31M | 133.22M | 133.97M | 43.23M | 44.52M | 45.31M | 36.15M | 28.94M | 27.46M | 21.97M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 95.11M | 98.1M | 101.14M | 105.81M | 172.47M | 176.08M | 183.19M | 153.31M | 155.15M | 154.11M | 154.02M | 64.36M | 63.62M | 56.64M | 51.23M | 37.48M | 45.09M | 53.72M |
Total Assets | 143.8M | 164.18M | 139.81M | 178.74M | 321.73M | 341.26M | 358.6M | 367.7M | 406.39M | 270.19M | 348.78M | 311.87M | 273.2M | 319.89M | 354.86M | 396.29M | 269.65M | 305.69M |
Account Payables | 2.2M | 2.17M | 4.08M | 8.25M | 4.81M | 5.22M | 3.64M | 8.96M | 12.92M | 12.3M | 17.44M | 10.45M | 13.99M | 6.79M | 13.73M | 8.62M | 5.45M | 4.88M |
Deferred Revenue | n/a | n/a | n/a | n/a | 7.92M | 8.11M | 7.73M | 9.83M | 3.63M | 2.38M | 4.26M | 4.87M | 11.1M | 20.44M | 16.82M | 21.62M | 19.83M | 21.24M |
Short-Term Debt | 9.48M | n/a | n/a | n/a | 9.2M | n/a | 6.68M | 6.28M | 5.47M | 4.78M | 456K | 7.33M | 7.06M | 6.85M | n/a | 9.35M | 6.3M | 3.34M |
Other Current Liabilities | 15.03M | 2.63M | 20.81M | 48.23M | 69.72M | 70.18M | 57.47M | 68.8M | 38.72M | 32.7M | 90.26M | 41.05M | 41.33M | 36.14M | 35.88M | 41.89M | 27.42M | 20.54M |
Total Current Liabilities | 30.94M | 31.32M | 41.22M | 64.83M | 108.28M | 98.48M | 98.66M | 79.22M | 77.9M | 63.82M | 85.6M | 81.82M | 89.04M | 82.36M | 82.26M | 94.59M | 56.16M | 47.86M |
Long-Term Debt | 77.96M | n/a | n/a | n/a | 102.49M | 102.01M | 101.54M | 101.14M | 100.74M | 51.23M | 50.59M | 50.86M | 50.63M | 50.44M | 24.64M | 16.12M | 19.04M | 21.87M |
Other Long-Term Liabilities | 1.95M | 1.9M | 1.84M | 4.72M | 1.73M | 1.81M | 2.17M | 2.54M | 3.5M | 1.49M | 1.44M | 961K | 943K | 3.91M | 11.49M | 8.2M | 1.12M | 777K |
Total Long-Term Liabilities | 79.91M | 82.39M | 84.8M | 89.99M | 300.52M | 302.52M | 304.8M | 303.6M | 305.88M | 254.25M | 252.41M | 162.46M | 161.1M | 156.57M | 141.09M | 125.96M | 112.42M | 114.13M |
Total Liabilities | 110.85M | 113.72M | 126.03M | 154.82M | 408.81M | 401M | 403.46M | 382.82M | 383.77M | 318.06M | 338M | 244.28M | 250.14M | 238.93M | 223.35M | 220.56M | 168.58M | 161.99M |
Total Debt | 87.43M | 89.55M | 91.64M | 93.61M | 212.63M | 214.18M | 213.94M | 212.28M | 212.92M | 162.71M | 162.59M | 76.04M | 77.21M | 77.63M | 49.21M | 43.79M | 44.84M | 39.66M |
Common Stock | 9K | 9K | 173K | 170K | 152K | 151K | 135K | 129K | 128K | 127K | 125K | 124K | 92K | 92K | 92K | 92K | 92K | 92K |
Retained Earnings | -965.27M | -945.42M | -978.1M | -962.46M | -1.05B | -1.02B | -978.24M | -936.99M | -889.13M | -935.68M | -864.51M | -795.72M | -735.71M | -670.98M | -614.35M | -564.35M | -632.57M | -584.24M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1K | 2K | -12K | -118K | -256K | -215K | -60K | 11K | 12K | -15K |
Shareholders Equity | 32.95M | 50.47M | 13.78M | 23.92M | -87.07M | -59.74M | -44.86M | -15.12M | 22.61M | -47.87M | 10.78M | 67.58M | 23.06M | 80.96M | 131.51M | 175.74M | 101.07M | 143.71M |
Total Investments | 8.67M | n/a | n/a | n/a | 9.87M | 9.83M | 9.59M | 9.59M | 9.59M | 11.7M | 18.31M | 27.61M | 68.97M | 94.81M | 111.2M | 125.72M | 155.44M | 205.97M |